Global Continuous Renal Replacement Therapy Market By Product Type (Dialysates and Replacement Fluids, Disposables, Systems), Therapies (Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodiafiltration (CVVHDF), Continuous Venovenous Hemodialysis (CVVHD), Slow Continuous Ultrafiltration (SCUF), End-User (Hospitals, Ambulatory Centers, Specially Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026
Market Analysis: Global Continuous Renal Replacement Therapy Market
Global continuous renal replacement therapy market is set to witness a substantial CAGR of 7.65% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. This rise in market value can be attributed to increasing demand for dental restoration procedures.
Market Definition: Global Continuous Renal Replacement Therapy Market
Continuous renal replacement therapy (CRRT) is used in constant and slow extracorporeal blood purification therapy for kidney failure patient. CRRT mimics the procedures of the kidneys in regulating water, electrolytes, and toxic products for the continuous slow removal of fluid and solutes. Continuous renal replacement therapy is only used for patients those are appropriate for hemodialysis therapy and incapable to bear conventional intermittent hemodialysis (IHD) due to hemodynamic instability. The demand for CRRT has widely enhanced as the product is helping surgeons to remove solutes in blood and tissue. Additionally demand for continuous renal replacement therapy is furthered expected to increase with ricing cases of acute kidney injury (AKI).
- Increasing global Incidence of Acute kidney injury (AKI) is expected to drive the growth of the market
- Increasing number of ICU Patients is expected to enhance the market growth
- Increasing technological advancement also acts as a market driver
- Increasing Incidence of Sepsis is expected to enhance growth of the market
- Continuous renal replacement therapy is costly procedures which are expected to restrain the market growth in the forecasted period.
- Stringent regulatory guidelines for continuous renal replacement therapy which is expected to hinder the market growth
- Lack of skilled professionals to perform continuous renal replacement therapy is hindering demand of this market
Segmentation: Global Continuous Renal Replacement Therapy Market
By Product Type
- Dialysates and Replacement Fluids
- Bloodline Sets (Tubing Sets)
- Other Disposables
- Continuous Venovenous Hemofiltration (CVVH)
- Continuous Venovenous Hemodiafiltration (CVVHDF)
- Continuous Venovenous Hemodialysis (CVVHD)
- Slow Continuous Ultrafiltration (SCUF)
By End User
- Ambulatory Centers
- Specially Clinics
- North America
- South America
- Rest of South America
- United Kingdom
- Rest of Europe
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa
Key Developments in the Market:
- In September 2019, Baxter has received approval for The PrisMax system from Health Canada. The PrisMax system is designed to treat kidney injury (AKI) in the ICU. The approval will help company to increase market presence and revenue generation as the company has simplified therapy and maximized accuracy and efficiency
- In January 2019, Spectral Medical Inc. has launched The Spectral CRRT in Canada and the United States. The product is designed to deliver support for acute renal injury that requires extracorporeal treatments in the ICU. The launch will help company to increase market presence in U.S. market as the company formed distribution partnership with a private U.S. company to distribute CRRT machines
Global continuous renal replacement therapy market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of continuous renal replacement therapy market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Competitors:
Few of the major competitors currently working in global continuous renal replacement therapy market are Baxter, Fresenius Medical Care AG & Co. KGaA, NxStage Medical, Inc., Nikkiso Co., Ltd., B. Braun Melsungen AG, Asahi Kasei Corporation, Bellco Società unipersonale a r.l., TORAY MEDICAL CO,.LTD., Infomed SA, Medica S.p.A., Medical Components, Inc., Medites Pharma spol. s.r.o., Medtronic, Informa Markets, Ningbo Tianyi Medical Devices Co., Ltd, cytosorbents, BIOMEDICA, Anjue Medical Equipment Co., Ltd., Jiangxi three medical Xin Science and technology limited, Proxima Medicare, NIPRO among others.
Research Methodology: Global Continuous Renal Replacement Therapy Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report
- Current and future of global continuous renal replacement therapy market outlook in the developed and emerging markets.
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
- All segmentation provided above in this report is represented at country level
- All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)